Teladoc Health, Inc.

NYSE:TDOC

Medical - Healthcare Information Services

Healthcare
$8.06 +2.57%

+$0.20 today

Market cap
$1.47B
Beta
2.14
P/E (TTM)
-8.1
EPS (TTM)
-$0.96
52W Low $4.40High $9.77

Volume 3.96M

Average 4.68M

TDOC Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

Teladoc Health, Inc.NYSE: TDOC

Weighted Avg Shares · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares grows in line with its trailing trend

Q1 FY2026 weighted avg shares of 179.12M shares rose 2.9% year over year, in line with the +2.8% change in trailing-twelve-month weighted avg shares. Sequentially, it rose 1.6% from the prior quarter. Over 3 fiscal years it compounded at +3.0% a year.

Context

  • Weighted avg shares increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +2.9% holds above the trailing-twelve-month pace of +2.8%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
179.12M+1.6% QoQ
Last fiscal yearDec 2025
176.22M+3.3% YoY
LTMMar 2026
176.73M+2.8% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+2.9%——
1 year+3.3%——
3-year CAGR+3.0%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
176.22M USD
Year-over-year change
+3.3%
4-year CAGR
+2.9%

Weighted Avg Shares vs competitors

How TDOC compares with its peers on the latest reported figures

  • TDOC's LTM Mar 2026 weighted avg shares of 176.73M shares is the 2nd highest of the 11 companies compared; the peer median is 69.98M shares.
  • Its year-over-year change of +2.8% is the 5th highest of 11, against a peer median of +1.8%.
  • Over three fiscal years its annual growth of +3.0% compares with a peer median of +1.4%.
TDOC Competitors Peer median
Weighted Avg Shares for TDOC and competitors
Company Period LTM YoY 3-year CAGR
EVOEvotec SELTM Mar 2026355.29M +0.6%+0.2%
TDOCTeladoc Health, Inc.LTM Mar 2026176.73M +2.8%+3.0%
NVCRNovoCure LimitedLTM Mar 2026112.28M +3.5%+2.1%
IMNMImmunome, Inc.LTM Sep 2026106.83M +34.8%+93.1%
PGNYProgyny, Inc.LTM Jun 202682.58M -6.4%-2.6%
SDGRSchrödinger, Inc.LTM Sep 202674.25M +1.4%+1.1%
PHVSPharvaris N.V.LTM Sep 202665.72M +16.6%+20.8%
PHRPhreesia, Inc.LTM Apr 202659.86M +3.0%+4.4%
OMDAOmada HealthLTM Mar 202656.91M +2.1%+1.6%
OMCLOmnicell, Inc.LTM Mar 202645.65M -1.2%+1.2%
AZTAAzenta, Inc.LTM Sep 202645.14M -1.3%-12.0%
Peer median (excluding TDOC) 69.98M+1.8%+1.4%

Competitors are the stored peer set for TDOC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue2.03B2.41B2.6B2.57B2.53B
Cost of Revenue650.26M743.99M760.03M751.27M771.59M
Gross Profit1.38B1.66B1.84B1.82B1.76B
Gross Margin68.0%69.1%70.8%70.8%69.5%
Research & Development311.88M333.63M348.52M307.27M277.92M
Selling, General & Admin1.11B1.3B1.37B1.35B1.09B
Operating Expenses1.65B15.32B2.09B2.84B2.02B
Depreciation & Amortization207.57M209.93M254.11M240.51M363.12M
EBITDA(31.42M)(7.54M)43.61M31.72M147.3M
EBITDA Margin-1.5%-0.3%1.7%1.2%5.8%
Operating Income(265.63M)(13.65B)(248.55M)(1.02B)(262.96M)
Operating Margin-13.1%-567.3%-9.6%-39.7%-10.4%
Interest Income776K12.67M46.78M57.07M36.77M
Interest Expense81.14M21.94M22.28M23.8M19.71M
Other Income / Expenses(119.03M)(10.13M)28.95M27.23M27.43M
Income Before Tax(384.66M)(13.66B)(219.61M)(993.65M)(235.53M)
Pre-Tax Margin-18.9%-567.7%-8.4%-38.7%-9.3%
Income Tax Expense44.14M(3.81M)760K7.59M(35.21M)
Net Income(428.79M)(13.66B)(220.37M)(1B)(200.32M)
Net Margin-21.1%-567.5%-8.5%-39.0%-7.9%
EPS (Basic)(2.73)(84.60)(1.36)(5.87)(1.14)
EPS (Diluted)(2.73)(84.60)(1.34)(5.87)(1.14)
Weighted Avg Shares156.94M161.46M162.17M170.56M176.22M
Weighted Avg Shares (Diluted)156.94M161.46M164.58M170.56M176.22M

Teladoc Health, Inc.

NYSE:TDOC

Intrinsic Alpha fair value

Locked

Current Price

$8.06

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.